Impregnation of plasmid DNA into three-dimensional scaffolds and medium perfusion enhance in vitro DNA expression of mesenchymal stem cells

Tissue Engineering

Volumn 11, Issue 9-10, 2005, Pages 1459-1475

  Hosseinkhani, Hossein ^a   Inatsugu, Yasuyuki ^a   Hiraoka, Yosuke ^a   Inoue, Sachiko ^a   Shimokawa, Hitoyata ^b   Tabata, Yasuhiko ^a  

^a KYOTO UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; COLLAGEN; ENZYME KINETICS; GENETIC ENGINEERING; IMPREGNATION; TISSUE CULTURE;

CULTURE METHODS; IN VITRO; PERFUSION; PLASMID DNA;

DNA;

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CARBOXYL GROUP; COLLAGEN; GELATIN; OSTEOCALCIN; PLASMID DNA; POLYGLYCOLIC ACID; SPERMINE;

ANIMAL TISSUE; ARTICLE; CELL CULTURE; COMPLEX FORMATION; CONTROLLED STUDY; FIBER; GENE EXPRESSION; IONIZATION; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PERFUSION; PRIORITY JOURNAL; RAT;

ALKALINE PHOSPHATASE; ANIMALS; BIOCOMPATIBLE MATERIALS; BONE MARROW CELLS; BONE MORPHOGENETIC PROTEINS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; COLLAGEN; CROSS-LINKING REAGENTS; CULTURE MEDIA; DESICCATION; DNA; FEMUR; GENE EXPRESSION; GLUTARAL; HEAT; KINETICS; MALE; MESENCHYMAL STEM CELLS; OSTEOCALCIN; OSTEOGENESIS; PERFUSION; PLASMIDS; POLYGLYCOLIC ACID; RATS; RATS, INBRED F344; TISSUE ENGINEERING; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; ULTRAVIOLET RAYS;

ANIMALIA;

EID: 27744545675     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2005.11.1459     Document Type: Article

References (82)

1. Kabanov, A.V., Felgner, P.L., and Seymour, L.W. (eds.). Self-Assembling Complexes for Gene Delivery. From Laboratory to Clinical Trial. New York: John Wiley & Sons, 1998.
2. Schreier, H. The new frontier: Gene and oligonucleotide therapy. Pharm. Acta Helv. 68, 145, 1994.
3. Tomlinson, E., and Rolland, A.P. Controllable gene therapy: Pharmaceutics of non-viral gene delivery systems. J. Control. Release 39, 357, 1996.
4. Ledley, F.D. Pharmaceutical approach to somatic gene therapy. Pharm. Res. 13, 1595, 1996.
5. Nolta J.A., Hanley, M.B., and Kohn, D.B. Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: Analysis of gene transduction of long-lived progenitors. Blood 83, 3041, 1994.
6. Bartholomew, A., Patil, S., Mackay, A., Nelson, M., Buyaner, D., Hardy, W., Mosca, J., Sturgeon, C., Siatskas, M., Mahmud, N., Ferrer, K., Deans, R., Moseley, A., Hoffman, R., and Devine, S.M. Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo. Hum. Gene Ther. 12, 1527, 2001.
7. Gazit, D., Turgeman, G., Kelley, P., Wang, E., Jalenak, M., Zilberman, Y., and Moutsatsos, I. Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: A novel cell mediated gene therapy. J. Gene Med. 1, 121, 1999.
8. Turgeman, G., Pittman, D.D., Müller, R., Kurkalli, B.G., Zhou, S., Felled, G., Peyser, A., Zilberman, Y., Moutsatsos, I.K., and Gazit, D. Engineered human mesenchymal stem cells: A novel platform for skeletal cell mediated gene therapy. J. Gene Med. 3, 240, 2001.
9. Lieberman, J.R., Daluiski, A., Stevenson, S., Wu, L., McAllister, P., Lee, Y.P., Kabo, J.M., Finerman, G.A., Berk, A.J., and Witte, O.N. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J. Bone Joint Surg. Am. 81, 905, 1999.
10. Lou, J., Xu, F., Merkel K., and Manske, P. Gene therapy: Adenovirus mediated human bone morphogenetic protein-2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo. J. Orthop. Res. 17, 43, 1999.
11. Wright, V.J., Peng, H., Usas, A., Young, B., Gearhart, B., Cummins, J., and Huard, J. BMP4-expressing muscle-derived stem cells differentiate into osteogenic lineage and improve bone healing in immunocompetent mice. Mol. Ther. 6, 169, 2002.
12. Musgrave, D.S., Bosch, V., Ghivizzani, S., Robbins, P.D., Evans, C.H., and Huard, J. Adenovirus-mediated direct gene therapy with bom: morphogenetic protein-2 produces bone. Bone 24, 541, 1999.
13. Dunn, C.A., Jin, Q., Taba, M., Jr., Franceschi, R.T., Bruce Rutherford, R., and Giannobile, W.V. BMP gene delivery for alveolar bone engineering at dental implant defects. Mol. Ther. 11, 294, 2005.
14. Boyne, P.J. Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects. J. Bone Joint Surg. Am. 83A(Suppl.), S146, 2001.
15. Fang, J., Zhu, Y.Y., Smiley, E., Bonadio, J., Rouleau, J.P., Goldstein, S.A., McCauley, L.K., Davidson, B.L., and Roessler, B.J. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc. Natl. Acad. Sci. U.S.A. 93, 5753, 1996.
16. Bonadio, J., Smiley, E., Patil, P., and Goldstein, S. Localized, direct plasmid gene delivery in vivo: Prolonged therapy results in reproducible tissue regeneration. Nat. Med. 5, 753, 1999.
17. Yoo., J.J., and Atala, A.A. A novel gene delivery system using urothelial tissue engineered neo-organs. J. Urol. 158, 1066, 1997.
18. Kloth, S., Ebenbeck, C., and Kubitza, M. Stimulation of renal micro vascular development under organotypic culture conditions. FASEB J. 9, 963, 1995.
19. Kloth, S., Echert, E., und Klein, S.J. Gastric epithelium under organotypic perfusion culture. In Vitro Cell Dev. Biol. Anim. 34, 515, 1998.
20. Minuth, W.W., Dermietzel, R., and Kloth, S. A new method of culturing renal cells under permanent perfusion and producing a luminal-basal medium gradient. Kidney Int. 41, 215, 1992.
21. Sittinger, M., Bujia, J., and Minuth, W.W. Engineering of cartilage tissue using bioresorbable polymer carriers in perfusion culture. Biomaterials 15, 451, 1994.
22. Schwartz, R.M., Palsson, B.O., and Emerson, S.G. Rapid medium perfusion rate significantly increase the productivity and longevity cf human bone marrow cultures. Proc. Natl. Acad. Sci. U.S A. 88, 6760, 1991.
23. Mueller, S., Mizuno, S., and Gerstenfeld, L. Medium perfusion enhances osteogenesis by murine osteosarcoma cells in three-dimensional collagen sponges. J. Bone Miner. Res. 14, 2118, 1999.
24. Glowacki, J., Mizuno, S., and Greenberger, J.S. Perfusion enhances inductions of bone marrow stromal cells in three-dimensional culture. Cell Transplant. 7, 319, 1998.
25. Mizuno, S., Allemann, F., and Glowacki, J. Effects of medium perfusion on matrix production by bovine chondrocytes in three-dimensional collagen sponges. J. Biomed. Mater. Res. 56, 368, 2001.
26. Castilho, L.R., and Medronho, R.A. Cell retention devices for suspended-cell perfusion cultures. Adv. Biochem. Eng. Biotechnol. 74, 129, 2002.
27. Yannas, I.V., Burke, J.F., Orgill, D.P., and Skrabut, E.M. Wound tissue can utilize a polymeric template to synthesize a functional extension of skin. Arch. Sci. 215, 174, 1982.
28. Snyder, S.L., and Sobocinski, P.Z. An improved 2,4,6- trinitrobenzenesulfonic acid method for the determination of amines. Anal. Biochem. 64, 284, 1975.
29. Hosseinkhani, H., Aoyama, T., Yamamoto, S., Ogawa, O., and Tabata, Y. In vitro transfection of plasmid DNA by amine derivatives of gelatin accompanied with ultrasound irradiation. Pharm. Res. 19, 1471, 2002.
30. Lennon, D.P., Haynesworth, S.E., Dennis, J.E., and Caplan, A.I. A chemically defined medium supports in vitro proliferation and maintains the osteochondral potential of rat marrow-derived mesenchymal stem cells. Exp. Cell Res. 219, 211, 1995.
31. Kawai, K., Suzuki, S., Tabata, Y., Taira, T., Ikada, Y., and Nishimura, Y. Development of an artificial dermis preparation capable of silver sulfadiazine release. J. Biomed. Mater. Res. 57, 346, 2001.
32. Hiraoka, Y., Kimura, Y., Ueda, H., and Tabata, Y. Fabrication and biocompatibility of collagen sponge reinforced with poly(glycolic acid) fiber. Tissue Eng. 9, 1101, 2003.
33. Hosseinkhani, H., Inatsugu, Y., Inoue, S., Hiraoka, Y., and Tabata, Y. Perfusion culture enhances the osteogenic differentiation of rat mesenchymal stem cells in collagen sponge reinforced with poly(glycolic acid) fiber. Tissue Eng 11, 1476, 2005.
34. Takahashi, Y., and Tabata, Y. Homogeneous seeding of mesenchymal stem cells into nonwoven fabric for tissue engineering. Tissue Eng. 9, 931, 2003.
35. Kim, B.S., Nikolovski, J., Bonadio, J., Smiley, E., and Mooney, D.J. Engineered smooth muscle tissues: Regulating cell phenotype with the scaffold. Exp. Cell Res. 251, 318, 1999.
36. Zimmermann, W.H., Fink, C., Kralisch, D., Remmers, U.W.J., and Eschenhagen, T. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol. Bioeng. 68, 106, 2000.
37. Partridge, K., Yang, X., Clarke, N.M., Okubo, Y., Bessho, K., Sebald, W., Howdle, S.M., Shakesheff, K.M., and Oreffo, R.O. Adenoviral BMP-2 gene transfer in mesenchymal stem cells: In vitro and in vivo bone formation on biodegradable polymer scaffolds. Biochem. Biophys. Res. Commun. 292, 144, 2002.
38. Minuth, W.W., Sittinger, M., and Kloth, S. Tissue engineering: Generation of differentiation of artificial tissues for biomedical applications. Cell Tissue Res. 291, 1, 1998.
39. Stenzel, K.H., Miyata, T., and Rubib, A.L. Collagen as a biomaterial. Annu. Rev. Biophys. Bioeng. 3, 231, 1974.
40. Rault, I., Frei, V., Herbage, D., Abdul-Makak, N., and Huc, A.E. Evaluation of different chemical methods for cross-linking collagen gel, film, and sponge. J. Mater. Sci. Mater. Med. 7, 215, 1996.
41. Friess, W. Collagen: Biomaterial for drug delivery. Eur. J. Pharm. Biopharm. 45, 113, 1998.
42. Teramachi, M., and Shimizu, Y. Porous-type tracheal prosthesis sealed with collagen sponge. Ann. Thorac. Surg. 64, 965, 1997.
43. Natsume, T., Ike, O., Okada, Takimoto, N., Shimizu, Y., and Ikada, Y. Porous collagen sponge for esophageal replacement. J. Biomed. Mater. Res. 27, 867, 1993.
44. Yamamoto, Y., Nakamura, T., Shimizu, Y., Takimoto, Y., Natsumoto, K., Kiyotani, T., Yu, L., Ueda, H., Sekine, T., and Tamaru, N. Experimental replacement of the thoracic esophagus with a bioabsorbable collagen sponge scaffold supported by a silicone stent in dogs. ASAIO J. 45, 311, 1999.
45. Kimura, Y., Ozeki, M., Inamoto, T., and Tabata, Y. Adipose tissue engineering based on human preadipocytes combined with gelatin microspheres containing basic fibroblast growth factor. Biomaterials 24, 2513, 2003.
46. Chamberlin, L.D., Yannas, I.V., Hsu, H.P., Strichhatz, G.R., and Spector, M. Near-terminus axonal structure and function following rat sciatic nerve regeneration through a collagen-GAG matrix in a ten-millimeter gap. J. Neurosci. Res. 60, 666, 2000.
47. Chen, G., Ushida, T., and Tateishi, T. Fabrication of PLGA-collagen hybrid sponge. Chem. Lett. 28, 561, 1999.
48. Ishaug-Riley, S.L., Crane-Kruger, G.M., Yamasaki, M.J., and Mikos, A.G. Three-dimensional culture of rat calvarial osteoblast in porous biodegradable polymers. Biomaterials 19, 1405, 1998.
49. Heimburg, D., Zachariah, S., Low, A., and Pallua, N. Influence of different biodegradable carriers on the in vivo behavior of human adipose precursor cells. Plast. Reconstr. Surg. 108, 411, 2001.
50. Weadock, K., Olson, R.M., and Silver, F.H. Evaluation of collagen crosslinking techniques. Biomater. Med. Devices Artif. Organs 11, 293, 1983-1984.
51. Wilke, M., Fortunati, E., VandenBroek, M., Hoogeveen, A.T., and Scholte, B.J. Efficacy of a peptide-based gene delivery system depends on mitotic activity. Gene Ther. 3, 1133, 1996.
52. Ingber, D.E., Prusty, D., Sun, Z., Betensky, H., and Wang, N. Cell shape, cytoskeletal mechanics, and cell cycle control in angiogenesis, J. Biomech. 28, 1471, 1995.
53. Webb, K., Hlady, V., and Tresco, P.A. Relationship among cell attachment, spreading, cytoskeletal organization, and migration rate for anchorage-dependent cells on model surfaces. J. Biomed. Mater. Res. 49, 362, 2000.
54. Keller, H., Yunxu, C., Marit, G., Pla, M., Reiffers, J., Theze, J., and Froussard, P. Transgene expression, but not gene delivery, is improved by adhesion-assisted lipofection of hematopoietic cells, Gene Ther. 6, 931, 1999.
55. Xie, Y., Yang, S.T., and Kniss, D. Three-dimensional cell-scaffold constructs promote efficient gene transfection: Implications for cell-based gene therapy. Tissue Eng. 7, 585, 2001.
56. Watanabe, Y., Ajioka, I., and Akaike, T. Gene transfection of multicellular spheroid of hepatocytes on an artificial substrate. Cytotechnology 26, 65, 1998.
57. Mason, J.M., Breitbart, A.S., Barcia, M., Porti, D., Pergolizzi, R.G., and Grande, D.A. Cartilage and bone regeneration using gene-enhanced tissue engineering. Clin. Orthop. Relat. Res. 379, S171, 2000.
58. Breitbart, A.S., Grande, D.A., Mason, J.M., Barcia, M., James, T., and Grant, R.T. Gene-enhanced tissue engineering: Applications for bone healing using cultured periosteal cells transduced retrovirally with the BMP-7 gene. Ann. Plast. Surg. 42, 488, 1999.
59. Breitbart, A.S., Mason, J.M., Urmacher, C., Barcia, M., Grant, R.T., Pergolizzi, R.G., and Grande, D.A. Gene-enhanced tissue engineering: Application for wound healing using cultured dermal fibroblasts transduced retrovirally with the PDGF-B gene. Ann. Plast. Surg. 43, 362, 1999.
60. Yoshikawa, T., Ohgushi, H., Akahane, M., Tamai, S., and Ichijima, K. Analysis of gene expression in osteogenic cultured marrow/hydroxyapatite construct implanted at ectopic sites: A comparison with the osteogenic ability of cancellous bone. J. Biomed. Mater. Res. 15, 568, 1998.
61. Noshi, T., Yoshikawa, T., Ikeuchi, M., Dohi, Y., Ohgushi, H., Horiuchi, K., Sugimura, M., Ichijima, K., and Yonemasu, K. Enhancement of the in vivo osteogenic potential of marrow/hydroxyapatite composites by bovine bone morphogenetic protein. J. Biomed. Mater. Res. 52, 621, 2000.
62. Koller, M.R., Bender, J.G., Papoutsakis, E.T., and Miller, W.M. Beneficial effects of reduced oxygen tension and perfusion in long-term hematopoietic cultures. Ann. N.Y. Acad. Sci. 665, 105, 1992.
63. Chesler, N.C., Thompson-Figueroa, J., and Millburne, K. Measurements of mouse pulmonary artery biomechanics. J. Biomech. Eng. 126, 309, 2004.
64. Cartmell, S.H., Porter, B.D., Garcia, A.J., and Guldberg, R.E. Effects of medium perfusion rate on cell-seeded three-dimensional bone constructs in vitro. Tissue Eng. 9, 1197, 2003.
65. Radisic, M., Yang, L., Boublik, J., Cohen, R.J., and Langer, R., Freed, L.E., and Vunjak-Novakovic, G. Medium perfusion enables engineering of compact and contractile cardiac tissue. Am. J. Physiol. Heart Circ. Physiol. 286, H507, 2004.
66. Minuth, W.W., Schumacher, K., and Strehl, R. Physiological and cell biological aspects of perfusion culture technique employed to generate differentiated tissues for long term biomaterial testing and tissue engineering. J. Biomater. Sci. Polym. Ed. 11, 495, 2000.
67. Koppelstaetter, C., Jennings, P., Ryan, M.P., Morin, J.P., Hartung, T., and Pfaller, W. Assessment of a new cell culture perfusion apparatus for in vitro chronic toxicity testing. 1. Technical description. ALTEX 21, 51, 2004.
68. Wendt, D., Marsano, A., Jakob, M., Heberer, M., and Martin, I. Oscillating perfusion of cell suspensions through three-dimensional scaffolds enhances cell seeding efficiency and uniformity. Biotechnol. Bioeng. 84, 205, 2003.
69. van den Dolder, J., Bancroft, G.N., Sikavitsas, V.I., Spauwen, P.H., Jansen, J.A., and Mikos, A.G. Flow perfusion culture of marrow stromal osteoblasts in titanium fiber mesh. J. Biomed. Mater. Res. 64, 235, 2003.
70. Sikavitsas, V.I., Bancroft, G.N., Holtorf, H.L., Jansen, J.A., and Mikos, A.G. Mineralized matrix deposition by marrow stromal osteoblasts in 3D perfusion culture increases with increasing fluid shear forces. Proc. Natl. Acad. Sci. U.S.A. 100, 14683, 2003.
71. Gomes, M.E., Sikavitsas, V.l., Behravesh, E., Reis, R.L., and Mikos, A.G. Effect of flow perfusion on the osteogenic differentiation of bone marrow stromal cells cultured on starch-based three-dimensional scaffolds. J. Biomed. Mater. Res. 67, 87, 2003.
72. Sittinger, M., Schultz, O., and Keyszer, G. Artificial tissues in perfusion culture. Int. J. Artif. Organs 20, 57, 1997.
73. Davisson, T., Sah, R.L., and Ratcliffe, A. Perfusion increases cell content and matrix synthesis in chondrocyte three-dimensional cultures. Tissue Eng. 8, 807, 2002.
74. Bancroft, G.N., Sikavitsas, V.I., van den Dolder, J., Sheffield, T.L., Ambrose, C.G., Jansen, J.A., and Mikos, A.G. Fluid flow increases mineralized matrix deposition in 3D perfusion culture of marrow stromal osteoblasts in a dose-dependent manner. Proc. Natl. Acad. Sci. U.S.A. 99, 12600, 2002.
75. Mueller-Klieser, W. Three-dimensional cell cultures: From molecular mechanisms to clinical applications. Am. J. Physiol. 273, C1109, 1997.
76. Shin, H., Zygourakis, K., Farach-Carson, M.C., Yaszemski, M.J., and Mikos, A.G. Modulation of differentiation and mineralization of marrow stromal cells cultured on biomimetic hydrogels modified with Arg-Gly-Asp containing peptides. J. Biomed. Mater. Res. 69, 535, 2004.
77. Yoshikawa, T., Ohgushi, H., and Tamai, S. Immediate bone forming capability of prefabricated osteogenic hydroxyapatite. J. Biomed. Mater. Res. 32, 481, 1996.
78. Lee, Y., Seol, Y., and Lim, Y. Tissue-engineered growth of bone by marrow cell transplantation using porous calcium metaphosphate matrices. J. Biomed. Mater. Res. 54, 216, 2001.
79. Wang, Y., Uemura, T., Dong, J., Kojima, H., Tanaka, J., and Takeishi, T. Application of perfusion culture systems improve in vitro and in vivo of bone marrow-derived osteoblastic cells in porous ceramic materials. Tissue Eng. 9, 1205, 2003.
80. Dohi, Y., Ohgushi, H., and Tabata, S. Osteogenesis associated with bone: Gla protein gene expression in diffusion chambers by bone marrow cells with demineralized bone matrix. J. Bone Miner. Res. 7, 1173, 1992.
81. Mundy, G.R. Bone Remodeling and Its Disorders, 2nd ed. London: Martin Dunitz, 1999.
82. Abdallah, B., Sachs, L., and Demeneix, B.A. Non-viral gene transfer: Applications in developmental biology and gene therapy. Biol. Coll 85, 1, 1995.